Dr. Reddy’s API Site in Mexico Receives U.S. FDA Warning

Pharmaceutical company Dr. Reddy’s Laboratories (Hyderabad, India) says that Industrias Quimicas Falcon de Mexico, its wholly owned manufacturing facility at Cuernavaca, Mexico has received a warning letter from the U.S. Food and Drug Administration (FDA). The facility produces intermediates and active pharmaceutical ingredients (API). An FDA inspection of the Cuernavaca facility in November 2010 identified certain deviations from current good manufacturing practice (cGMP) for the manufacture of APIs, the FDA says. Dr. Reddy’s says it responded to the...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers